毕得医药：股东减持股份计划公告

Core Points - Bid Pharma announced that its controlling shareholder, Dai Lan, holds 29,664,719 shares, accounting for 32.64% of the total shares [2] - Dai Lan plans to reduce her holdings by up to 148,835 shares, which represents 0.16% of the company's total share capital, within three months after the disclosure of the reduction plan [2] - The reduction will be executed through centralized bidding based on market conditions [2]